“…However, it remains uncertain whether NETs play a causal role in initiating thrombosis or are merely associated with thrombotic events. 70 Risk of bleeding was sought by Lahu et al 71 who identified an association with soluble glycoprotein VI levels but no increased risk of ischemic events in patients undergoing elective percutaneous coronary intervention. This identifies soluble glycoprotein VI as a potential biomarker that warrants deeper investigation to assess its viability as a tool for personalized patient care.…”